Mometasone / Olopatadine Nasal Dosage

Medically reviewed by Drugs.com. Last updated on Dec 8, 2022.

Usual Adult Dose for Allergic Rhinitis

2 sprays in each nostril twice a day

Use: For the treatment of symptoms of seasonal allergic rhinitis

Usual Pediatric Dose for Allergic Rhinitis

12 years or older: 2 sprays in each nostril twice a day

Use: For the treatment of symptoms of seasonal allergic rhinitis

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Comments:

• No studies have been conducted with this drug in patients with liver dysfunction; however, there have been reports of mometasone levels appearing to increase with severity of liver dysfunction.

Precautions

CONTRAINDICATIONS:

• Known hypersensitivity to either active component or to any of the ingredients

Safety and efficacy have not been established in patients younger than 12 years.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:

• For nasal use only
• Shake the bottle well before each use.
• Before initial use, prime this drug by releasing 6 sprays; when this drug has not been used for at least 14 days, re-prime by releasing 2 sprays or until a fine mist appears.
• Do not spray into the eyes or mouth.
• Discard the bottle after 240 sprays have been used; the correct dose of medication may not be delivered even though the bottle may not be completely empty.

Storage requirements:

• Store upright with dust cap on at room temperature (20C to 25C [68F to 77F]; excursions permitted to 15C to 30C [59F to 86F]).
• Do not store in freezer or refrigerator.

General:

• Each spray delivers 0.1 mL suspension containing mometasone furoate 25 mcg and olopatadine hydrochloride 665 mcg.

Monitoring:

• Infections/Infestations: For evidence of Candida infection (periodically if used over several months or longer)
• Musculoskeletal: Growth of pediatric patients (regularly during therapy)
• Respiratory: For signs of adverse effects on the nasal mucosa (periodically)

Patient advice:

• Read the US FDA-approved patient labeling (Patient Information and Instructions for Use).
• Do not engage in hazardous activities requiring complete mental alertness and motor coordination (e.g., driving, operating machinery) after use of this drug; somnolence has been reported.
• Avoid concurrent use of this drug with alcohol or other CNS depressants.
• Discontinue this drug if hypersensitivity reactions (including wheezing) occur.
• Avoid exposure to chickenpox or measles; if exposed, seek medical advice without delay.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer